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Few studies have examined the association between passive smoking and the risk of oesophageal and gastric adenocarcinomas. In a
population-based case–control study with 2474 participants in Los Angeles County, there was no evidence that passive smoking had
any appreciable effect on oesophageal or gastric adenocarcinomas.
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Tobacco smoking is a well-established cause of oesophageal
squamous cell carcinoma (ESCC) and oesophageal adeno-
carcinoma (EA) (IARC, 2004). Generally, the risk for both types
of oesophageal cancer increases with increasing duration of
smoking and remains high for a number of years after smoking
cessation (IARC, 2004). The literature on smoking and stomach
cancer also shows a consistent association with cigarette smoking
in both men and women (IARC, 2004; Ladeiras-Lopes et al, 2008).
Alcohol drinking is thought to be associated with ESCC (Freedman
et al, 2007), but not with EA (Wu et al, 2001), and is not directly
related to gastric cancer (Chow, 1999). Although much attention
has been focused on the association between active smoking and
cancer risk, less has been paid to the association between passive
smoking and cancer risk, with the exception of lung cancer (IARC,
2004). A few studies have investigated gastric cancer in relation to
passive smoking (Hirayama, 1984; Sandler et al, 1989; Nishino
et al, 2001; Mao et al, 2002), but none has reported on EA.
We investigated the relationship between passive smoking and
the oesophageal and gastric adenocarcinoma (EGA) risks in a
population-based case–control study in Los Angeles County.
MATERIALS AND METHODS
The details of the study population and design have been described
elsewhere (Wu et al, 2001). Briefly, 1716 eligible patients with newly
diagnosed first-incident EA, gastric cardia adenocarcinoma (GCA),
or distal gastric adenocarcinoma (DGA) between 1992 and 1997
were identified and contacted for participation through the
population-based, Los Angeles County Cancer Surveillance Pro-
gram. Neighbourhood controls were matched individually to each
case patient on sex, race, and age (±5 years). To increase statistical
power, we sought two controls for each case whenever possible. In-
person interviews were conducted using a structured questionnaire
to gather information on demographics, smoking status, smoking
history, and household passive smoking exposure during childhood
and adulthood. Intensity of passive smoking exposure was measured
by the number of smokers who smoked in the participant’s presence
for at least 1 year and the duration of each exposure. These smokers
included the participant’s spouse, parents, siblings, or other
relatives. Next-of-kin (NOK) were interviewed when case patients
were unable to be interviewed due to death or illness. However, we
were unable to interview 769 patients who were too ill or died and
had no NOK available for interview, whose physicians denied
permission to contact, or who refused to participate or could not be
located. After excluding participants due to missing information, a
total of 938 (220 EA/277 GCA/441 DGA) case patients and 1356
control participants are included in the analyses presented. Age, sex,
and race distributions did not differ between the case patients we
interviewed and those we did not. Next-of-kin accounted for 269 of
the 938 interviews with case patients (65 EA/85 GCA/119 DGA).
We obtained odds ratios (ORs) and 95% confidence intervals
(CIs) using polychotomous logistic regression, which allowed us to
evaluate ORs for the different cancer sites simultaneously. We
adjusted for age, gender (female vs male), body mass index (BMI)
(kgm
 2), and ethnicity (others vs non-Hispanic white). For validity
purposes, we repeated all statistical analyses excluding NOK data.
Risk estimates were not materially different from the results based on
all subjects combined (i.e., self-respondents and NOK respondents).
RESULTS
The mean ages of case patients at diagnosis were 62.2 years
(s.d.¼9.2) for EA patients, 58.7 years (s.d.¼12.9) for GCA
patients, and 58.0 years (s.d.¼12.5) for DGA patients; control
participants were, on average, 57.0 years old (s.d.¼12.5) on their
reference dates (date identified). Among control participants,
60.3% were male, compared with 81.4% of EA patients, 63.4% of
GCA patients, and 37.4% of DGA patients. Non-Latino whites
represented 72.1% of EA patients, 63.4% of GCA patients, and
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y24.1% of DGA patients. Oesophageal adenocarcinoma and GCA
patients tended to have greater BMI than control participants.
Considering all 2294 participants, 769 (33.5%) never smoked any
cigarette or other tobacco (i.e., never smoked at least one cigarette
a day for 6 months or longer), 1050 (45.8%) were ex-smokers, and
475 (20.7%) were current smokers.
Current smokers were at increased EA risk (adjusted OR, 3.27;
95% CI: 1.56–6.86), increased GCA risk (adjusted OR, 2.07; 95%
CI: 1.16–3.69), and increased DGA risk (adjusted OR, 1.83; 95% CI:
1.13–2.99) relative to never smokers who had no passive smoke
exposure (Table 1). Never smokers exposed to passive smoking
during childhood were not at increased risk of adenocarcinomas of
the oesophagus, gastric cardia, or distal stomach compared with
never smokers with no passive smoke exposure. The risks did not
differ between participants who were exposed to passive cigarette
smoke only and those who were also passively exposed to other
tobacco products (e.g., cigar or pipe). Exposure to at least one
smoker during adulthood was associated with an elevated risk for
EA (adjusted OR, 1.80; 95% CI: 0.81–4.00); similar results were
observed for duration of exposure. Those exposed to passive
smoking as adults whether for fewer, or for more, than 12 person-
years were at increased risk for EA and DGA, although the CIs
were wide and included 1.0. Trend test indicated a dose–response
effect for DGA (Ptrend¼0.03). No other associations were observed.
DISCUSSION
We found no evidence that exposure of persons who have never
actively smoked to passive smoke during their childhood years or
during their adult years strongly influences their risk of EGA. We
found nonsignificantly elevated risks of EA and DGA for adult
passive smoke exposure.
Direct cigarette smoking plays an important role in the
development of oesophageal and gastric cancers (IARC, 2004),
for which laboratory studies provide some potential mechanisms.
In animal models, cigarette smoke exposure significantly decrea-
sed serum epidermal growth factor (EGF) levels (Ma et al, 1999).
Although the mechanisms by which cigarette smoke exposure
decreases serum EGF are still unknown, depletion of EGF has been
associated with reduced gastric blood flow, which in turn, results
in the promotion of apoptosis in the gastric mucosa (Ma et al,
1999; Wang et al, 2000). The contents of cigarette smoke may form
DNA adducts and induce mutations in tumour suppressor genes
(Shin and Cho, 2005). Tobacco smoking may also increase the risk
of EA by reducing lower oesophageal sphincter pressure, thereby
promoting reflux disease (Dua et al, 1998; Pandolfino and Kahrilas,
2000). Using this study population, we have shown earlier that
current cigarette smokers have increased risk for EA, GCA, and
DGA, and that the deleterious effect on the oesophagus remained
for at least 20 years after smoking cessation (Wu et al, 2001). In
these earlier analyses, the reference group combined never smokers
with passive smoke exposure and those without such exposure.
Few studies have examined the association between passive
smoking and the risk of gastric adenocarcinoma (Hirayama, 1984;
Sandler et al, 1989; Jee et al, 1999; Nishino et al, 2001; Mao et al,
2002). In a Japanese cohort study, after 16 years of follow-up,
elevated risks of lung cancer were observed in non-smoking
women whose husbands smoked (Hirayama, 1984). Although
similar risk increases were also observed for nasal sinus cancer,
brain tumours, and cancer overall, none of these associations were
statistically significant; no associations were noted specifically for







Exposure to smoking Control n OR
a (95% CI) N OR
a (95% CI) n OR
a (95% CI)
Lifetime exposure to smoke (active and passive)
No active, no passive 122 12 — 17 — 38 —
No active, passive exposure in childhood only 151 6 0.48 (0.17–1.42) 20 0.89 (0.44–1.79) 34 0.85 (0.48–1.53)
No active, any passive exposure in adulthood
b 207 22 1.49 (0.65–3.40) 32 0.86 (0.44–1.67) 85 1.30 (0.79–2.14)
Ex-smoker 639 107 1.55 (0.76–3.19) 127 1.07 (0.61–1.86) 177 1.28 (0.82–2.01)
Current smoker 236 70 3.27 (1.56–6.86) 79 2.07 (1.16–3.70) 90 1.82 (1.12–2.97)
Passive exposure type among never smokers
No passive smoke exposure 122 12 — 17 — 38 —
Exposure to cigarette only 298 23 1.05 (0.46–2.39) 41 0.79 (0.42–1.48) 97 1.04 (0.64–1.70)
Exposure to other types of tobacco
c 61 4 0.67 (0.19–2.35) 11 0.87 (0.36–2.10) 22 1.25 (0.61–2.55)
No. of persons who smoke in households of never smokers
Childhood
No childhood exposure 178 20 — 24 — 70 —
1 206 13 0.58 (0.27–1.26) 23 0.76 (0.40–1.42) 51 0.72 (0.45–1.14)
2+ 93 5 0.47 (0.15–1.52) 20 1.36 (0.67–2.77) 23 0.82 (0.45–1.49)
Adulthood
No adult exposure 273 18 — 37 — 72 —
1 141 14 1.80 (0.81–4.00) 20 0.72 (0.37–1.42) 58 1.38 (0.86–2.21)
2+ 66 6 1.34 (0.46–3.93) 12 1.04 (0.49–2.22) 27 1.23 (0.66–2.29)
Duration of passive smoke exposure among never smokers
Adulthood
No adult exposure 273 18 — 37 — 72 —
o12 person-exposure years 112 10 1.54 (0.64–3.72) 11 0.55 (0.25–1.20) 34 1.15 (0.67–1.97)
X12 person-exposure years 95 10 1.77 (0.73–4.32) 21 1.08 (0.54–2.16) 51 1.54 (0.92–2.58)
P for trend
d 0.43 0.60 0.03
CI¼confidence interval; OR¼odds ratio.
aORs from polychotomous logistic regression models, adjusted for age, gender, body mass index at reference age, and ethnicity
(others vs non-Hispanic white).
bMight or might not be exposed during childhood.
cOther types of tobacco include cigar, pipe, or a combination of these.
dTrend statistics was
calculated using continuous measure of exposed duration in person-exposure years.
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yoesophageal or gastric cancer (Hirayama, 1984). Whether passive
smoking at home affected cancer incidence among non-smoking
Japanese women was investigated by linking cohort and cancer
registry data (Nishino et al, 2001). The results, after 9 years of
follow-up, indicated that a husband’s smoking might increase the
non-smoking woman’s risk of ‘smoking-related cancer’ overall
(i.e., oral, oropharyngeal, hypopharyngeal, oesophageal, pancreatic,
laryngeal, lung, bladder, or renal pelvis cancer), but not signi-
ficantly. Further, a husband’s smoking status was unrelated to the
non-smoking woman’s risk of gastric cancer. No results were
presented for oesophageal cancer. A limitation of this study is that
household members’ smoking status was collected only at baseline.
In a Canadian population-based case–control study of stomach
cancer that separated cancer subsite (cardia vs distal), passive
smoke exposure was positively associated with gastric cardia cancer
risk in a dose–response manner among male never smokers (Mao
et al, 2002). In contrast, we observed a potentially increased risk of
DGA, but not GCA, associated with passive smoke exposure among
non-smokers; we were unable to perform the stratified analyses by
gender because of the small number of never smokers.
The findings of our study, the first to evaluate passive smoke
exposure and risk of EGA in a western population, are essentially
negative, but are limited by the small number of never smokers.
Larger studies and more precise exposure estimates are needed for
more definitive conclusions.
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